nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MTR—breast cancer	0.532	1	CbGaD
Hydroxocobalamin—Cyanocobalamin—MTR—breast cancer	0.00393	0.745	CrCbGaD
Hydroxocobalamin—CASP9—mammary gland—breast cancer	0.00321	0.0361	CbGeAlD
Hydroxocobalamin—MUT—mammary gland—breast cancer	0.00247	0.0277	CbGeAlD
Hydroxocobalamin—CUBN—epithelium—breast cancer	0.00216	0.0243	CbGeAlD
Hydroxocobalamin—MUT—nipple—breast cancer	0.00204	0.0229	CbGeAlD
Hydroxocobalamin—MMACHC—endocrine gland—breast cancer	0.00196	0.022	CbGeAlD
Hydroxocobalamin—MTR—mammary gland—breast cancer	0.00193	0.0217	CbGeAlD
Hydroxocobalamin—MTRR—nipple—breast cancer	0.00183	0.0206	CbGeAlD
Hydroxocobalamin—CUBN—pituitary gland—breast cancer	0.00175	0.0197	CbGeAlD
Hydroxocobalamin—CUBN—adipose tissue—breast cancer	0.00175	0.0196	CbGeAlD
Hydroxocobalamin—TCN1—endometrium—breast cancer	0.00174	0.0196	CbGeAlD
Hydroxocobalamin—MMAA—adipose tissue—breast cancer	0.00165	0.0186	CbGeAlD
Hydroxocobalamin—CUBN—female reproductive system—breast cancer	0.0016	0.018	CbGeAlD
Hydroxocobalamin—MTR—nipple—breast cancer	0.0016	0.018	CbGeAlD
Hydroxocobalamin—CUBN—adrenal gland—breast cancer	0.00157	0.0176	CbGeAlD
Hydroxocobalamin—MMAB—pituitary gland—breast cancer	0.00155	0.0175	CbGeAlD
Hydroxocobalamin—MMAB—adipose tissue—breast cancer	0.00155	0.0174	CbGeAlD
Hydroxocobalamin—MMAA—adrenal gland—breast cancer	0.00148	0.0167	CbGeAlD
Hydroxocobalamin—CUBN—female gonad—breast cancer	0.00146	0.0164	CbGeAlD
Hydroxocobalamin—CASP9—adipose tissue—breast cancer	0.00145	0.0163	CbGeAlD
Hydroxocobalamin—MMAB—female reproductive system—breast cancer	0.00142	0.016	CbGeAlD
Hydroxocobalamin—TCN2—pituitary gland—breast cancer	0.00142	0.0159	CbGeAlD
Hydroxocobalamin—TCN2—adipose tissue—breast cancer	0.00141	0.0159	CbGeAlD
Hydroxocobalamin—MMAB—adrenal gland—breast cancer	0.00139	0.0156	CbGeAlD
Hydroxocobalamin—MMAA—female gonad—breast cancer	0.00138	0.0155	CbGeAlD
Hydroxocobalamin—TCN1—bone marrow—breast cancer	0.00136	0.0153	CbGeAlD
Hydroxocobalamin—CUBN—endocrine gland—breast cancer	0.00136	0.0153	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—MTHFR—breast cancer	0.00135	0.255	CrCbGaD
Hydroxocobalamin—CASP9—female reproductive system—breast cancer	0.00133	0.015	CbGeAlD
Hydroxocobalamin—TCN2—female reproductive system—breast cancer	0.0013	0.0146	CbGeAlD
Hydroxocobalamin—CASP9—adrenal gland—breast cancer	0.0013	0.0146	CbGeAlD
Hydroxocobalamin—MMAB—female gonad—breast cancer	0.00129	0.0146	CbGeAlD
Hydroxocobalamin—MMAA—endocrine gland—breast cancer	0.00128	0.0144	CbGeAlD
Hydroxocobalamin—TCN2—adrenal gland—breast cancer	0.00127	0.0142	CbGeAlD
Hydroxocobalamin—MUT—endometrium—breast cancer	0.00123	0.0139	CbGeAlD
Hydroxocobalamin—CASP9—female gonad—breast cancer	0.00121	0.0136	CbGeAlD
Hydroxocobalamin—MMAB—endocrine gland—breast cancer	0.0012	0.0135	CbGeAlD
Hydroxocobalamin—MUT—uterus—breast cancer	0.00113	0.0128	CbGeAlD
Hydroxocobalamin—CASP9—endocrine gland—breast cancer	0.00112	0.0127	CbGeAlD
Hydroxocobalamin—AMN—lymph node—breast cancer	0.00111	0.0125	CbGeAlD
Hydroxocobalamin—MUT—pituitary gland—breast cancer	0.00111	0.0125	CbGeAlD
Hydroxocobalamin—MUT—adipose tissue—breast cancer	0.00111	0.0125	CbGeAlD
Hydroxocobalamin—MTRR—endometrium—breast cancer	0.00111	0.0124	CbGeAlD
Hydroxocobalamin—TCN2—endocrine gland—breast cancer	0.0011	0.0123	CbGeAlD
Hydroxocobalamin—MUT—female reproductive system—breast cancer	0.00102	0.0115	CbGeAlD
Hydroxocobalamin—MTRR—uterus—breast cancer	0.00102	0.0115	CbGeAlD
Hydroxocobalamin—MTRR—pituitary gland—breast cancer	0.001	0.0113	CbGeAlD
Hydroxocobalamin—MTRR—adipose tissue—breast cancer	0.000997	0.0112	CbGeAlD
Hydroxocobalamin—MUT—adrenal gland—breast cancer	0.000996	0.0112	CbGeAlD
Hydroxocobalamin—MTR—endometrium—breast cancer	0.000965	0.0109	CbGeAlD
Hydroxocobalamin—MUT—bone marrow—breast cancer	0.000963	0.0108	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—breast cancer	0.000938	0.0106	CbGeAlD
Hydroxocobalamin—MUT—female gonad—breast cancer	0.000928	0.0104	CbGeAlD
Hydroxocobalamin—MTRR—female reproductive system—breast cancer	0.000917	0.0103	CbGeAlD
Hydroxocobalamin—MTRR—adrenal gland—breast cancer	0.000895	0.0101	CbGeAlD
Hydroxocobalamin—MTR—uterus—breast cancer	0.000889	0.01	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—breast cancer	0.000887	0.00998	CbGeAlD
Hydroxocobalamin—MTR—pituitary gland—breast cancer	0.000873	0.00983	CbGeAlD
Hydroxocobalamin—MTR—adipose tissue—breast cancer	0.00087	0.00979	CbGeAlD
Hydroxocobalamin—MTRR—bone marrow—breast cancer	0.000865	0.00974	CbGeAlD
Hydroxocobalamin—MUT—endocrine gland—breast cancer	0.000863	0.00971	CbGeAlD
Hydroxocobalamin—MTRR—female gonad—breast cancer	0.000834	0.00938	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—breast cancer	0.000832	0.00936	CbGeAlD
Hydroxocobalamin—MTR—female reproductive system—breast cancer	0.0008	0.00899	CbGeAlD
Hydroxocobalamin—MTR—adrenal gland—breast cancer	0.00078	0.00878	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—breast cancer	0.000778	0.00875	CbGeAlD
Hydroxocobalamin—MTRR—endocrine gland—breast cancer	0.000776	0.00873	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—breast cancer	0.000759	0.00854	CbGeAlD
Hydroxocobalamin—MTR—bone marrow—breast cancer	0.000755	0.00849	CbGeAlD
Hydroxocobalamin—MTR—female gonad—breast cancer	0.000728	0.00818	CbGeAlD
Hydroxocobalamin—MTR—endocrine gland—breast cancer	0.000677	0.00761	CbGeAlD
Hydroxocobalamin—MUT—lymph node—breast cancer	0.000597	0.00671	CbGeAlD
Hydroxocobalamin—MTRR—lymph node—breast cancer	0.000536	0.00603	CbGeAlD
Hydroxocobalamin—MTR—lymph node—breast cancer	0.000468	0.00526	CbGeAlD
Hydroxocobalamin—Erythema—Docetaxel—breast cancer	9.16e-05	0.00053	CcSEcCtD
Hydroxocobalamin—Chills—Capecitabine—breast cancer	9.14e-05	0.000529	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	9.13e-05	0.000529	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Fluorouracil—breast cancer	9.11e-05	0.000527	CcSEcCtD
Hydroxocobalamin—Nausea—Tamoxifen—breast cancer	9.1e-05	0.000527	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Capecitabine—breast cancer	9.1e-05	0.000526	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Gemcitabine—breast cancer	9.09e-05	0.000526	CcSEcCtD
Hydroxocobalamin—Discomfort—Paclitaxel—breast cancer	9.09e-05	0.000526	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—breast cancer	9.08e-05	0.000525	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—breast cancer	9.02e-05	0.000522	CcSEcCtD
Hydroxocobalamin—Pain—Gemcitabine—breast cancer	9e-05	0.000521	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vinorelbine—breast cancer	8.97e-05	0.000519	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Fluorouracil—breast cancer	8.94e-05	0.000517	CcSEcCtD
Hydroxocobalamin—Mental disorder—Capecitabine—breast cancer	8.92e-05	0.000516	CcSEcCtD
Hydroxocobalamin—Nausea—Melphalan—breast cancer	8.91e-05	0.000516	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Mitoxantrone—breast cancer	8.91e-05	0.000516	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Irinotecan—breast cancer	8.91e-05	0.000516	CcSEcCtD
Hydroxocobalamin—Erythema—Capecitabine—breast cancer	8.86e-05	0.000513	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—breast cancer	8.86e-05	0.000513	CcSEcCtD
Hydroxocobalamin—Pruritus—Thiotepa—breast cancer	8.86e-05	0.000513	CcSEcCtD
Hydroxocobalamin—Pain—Fluorouracil—breast cancer	8.85e-05	0.000512	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Paclitaxel—breast cancer	8.82e-05	0.00051	CcSEcCtD
Hydroxocobalamin—Oedema—Paclitaxel—breast cancer	8.82e-05	0.00051	CcSEcCtD
Hydroxocobalamin—Infection—Paclitaxel—breast cancer	8.76e-05	0.000507	CcSEcCtD
Hydroxocobalamin—Nausea—Goserelin—breast cancer	8.69e-05	0.000503	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Gemcitabine—breast cancer	8.68e-05	0.000502	CcSEcCtD
Hydroxocobalamin—Dizziness—Vinorelbine—breast cancer	8.67e-05	0.000502	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Paclitaxel—breast cancer	8.65e-05	0.0005	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—breast cancer	8.64e-05	0.0005	CcSEcCtD
Hydroxocobalamin—Tachycardia—Paclitaxel—breast cancer	8.6e-05	0.000498	CcSEcCtD
Hydroxocobalamin—Urticaria—Mitoxantrone—breast cancer	8.59e-05	0.000497	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Thiotepa—breast cancer	8.56e-05	0.000496	CcSEcCtD
Hydroxocobalamin—Skin disorder—Paclitaxel—breast cancer	8.56e-05	0.000496	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Mitoxantrone—breast cancer	8.55e-05	0.000495	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Irinotecan—breast cancer	8.55e-05	0.000495	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Fluorouracil—breast cancer	8.53e-05	0.000494	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Gemcitabine—breast cancer	8.32e-05	0.000482	CcSEcCtD
Hydroxocobalamin—Dizziness—Thiotepa—breast cancer	8.28e-05	0.000479	CcSEcCtD
Hydroxocobalamin—Rash—Vinorelbine—breast cancer	8.26e-05	0.000478	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vinorelbine—breast cancer	8.26e-05	0.000478	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Capecitabine—breast cancer	8.23e-05	0.000476	CcSEcCtD
Hydroxocobalamin—Urticaria—Fluorouracil—breast cancer	8.22e-05	0.000476	CcSEcCtD
Hydroxocobalamin—Headache—Vinorelbine—breast cancer	8.21e-05	0.000475	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—breast cancer	8.2e-05	0.000475	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Fluorouracil—breast cancer	8.18e-05	0.000474	CcSEcCtD
Hydroxocobalamin—Malaise—Capecitabine—breast cancer	7.99e-05	0.000463	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Irinotecan—breast cancer	7.96e-05	0.000461	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Mitoxantrone—breast cancer	7.96e-05	0.000461	CcSEcCtD
Hydroxocobalamin—Rash—Thiotepa—breast cancer	7.89e-05	0.000457	CcSEcCtD
Hydroxocobalamin—Dermatitis—Thiotepa—breast cancer	7.89e-05	0.000456	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Paclitaxel—breast cancer	7.86e-05	0.000455	CcSEcCtD
Hydroxocobalamin—Headache—Thiotepa—breast cancer	7.84e-05	0.000454	CcSEcCtD
Hydroxocobalamin—Chest pain—Docetaxel—breast cancer	7.8e-05	0.000451	CcSEcCtD
Hydroxocobalamin—Nausea—Vinorelbine—breast cancer	7.79e-05	0.000451	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Paclitaxel—breast cancer	7.76e-05	0.000449	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.74e-05	0.000448	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Fluorouracil—breast cancer	7.63e-05	0.000441	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Paclitaxel—breast cancer	7.61e-05	0.00044	CcSEcCtD
Hydroxocobalamin—Chest pain—Capecitabine—breast cancer	7.55e-05	0.000437	CcSEcCtD
Hydroxocobalamin—Pain—Paclitaxel—breast cancer	7.54e-05	0.000436	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.5e-05	0.000434	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—breast cancer	7.49e-05	0.000433	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Docetaxel—breast cancer	7.47e-05	0.000432	CcSEcCtD
Hydroxocobalamin—Oedema—Docetaxel—breast cancer	7.47e-05	0.000432	CcSEcCtD
Hydroxocobalamin—Discomfort—Capecitabine—breast cancer	7.46e-05	0.000432	CcSEcCtD
Hydroxocobalamin—Pruritus—Gemcitabine—breast cancer	7.45e-05	0.000431	CcSEcCtD
Hydroxocobalamin—Nausea—Thiotepa—breast cancer	7.44e-05	0.00043	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Methotrexate—breast cancer	7.43e-05	0.00043	CcSEcCtD
Hydroxocobalamin—Infection—Docetaxel—breast cancer	7.42e-05	0.00043	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mitoxantrone—breast cancer	7.4e-05	0.000428	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Irinotecan—breast cancer	7.4e-05	0.000428	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Docetaxel—breast cancer	7.33e-05	0.000424	CcSEcCtD
Hydroxocobalamin—Pruritus—Fluorouracil—breast cancer	7.32e-05	0.000424	CcSEcCtD
Hydroxocobalamin—Tachycardia—Docetaxel—breast cancer	7.29e-05	0.000422	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Paclitaxel—breast cancer	7.27e-05	0.00042	CcSEcCtD
Hydroxocobalamin—Skin disorder—Docetaxel—breast cancer	7.26e-05	0.00042	CcSEcCtD
Hydroxocobalamin—Oedema—Capecitabine—breast cancer	7.23e-05	0.000419	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Gemcitabine—breast cancer	7.2e-05	0.000417	CcSEcCtD
Hydroxocobalamin—Infection—Capecitabine—breast cancer	7.19e-05	0.000416	CcSEcCtD
Hydroxocobalamin—Dizziness—Irinotecan—breast cancer	7.15e-05	0.000414	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Capecitabine—breast cancer	7.1e-05	0.000411	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—breast cancer	7.08e-05	0.00041	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Fluorouracil—breast cancer	7.08e-05	0.00041	CcSEcCtD
Hydroxocobalamin—Tachycardia—Capecitabine—breast cancer	7.06e-05	0.000409	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—breast cancer	7.04e-05	0.000407	CcSEcCtD
Hydroxocobalamin—Skin disorder—Capecitabine—breast cancer	7.03e-05	0.000407	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—breast cancer	7.01e-05	0.000405	CcSEcCtD
Hydroxocobalamin—Urticaria—Paclitaxel—breast cancer	7e-05	0.000405	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—breast cancer	6.99e-05	0.000404	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Paclitaxel—breast cancer	6.97e-05	0.000403	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—breast cancer	6.95e-05	0.000402	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—breast cancer	6.88e-05	0.000398	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—breast cancer	6.85e-05	0.000396	CcSEcCtD
Hydroxocobalamin—Dizziness—Fluorouracil—breast cancer	6.85e-05	0.000396	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—breast cancer	6.83e-05	0.000395	CcSEcCtD
Hydroxocobalamin—Rash—Irinotecan—breast cancer	6.82e-05	0.000394	CcSEcCtD
Hydroxocobalamin—Rash—Mitoxantrone—breast cancer	6.82e-05	0.000394	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mitoxantrone—breast cancer	6.81e-05	0.000394	CcSEcCtD
Hydroxocobalamin—Dermatitis—Irinotecan—breast cancer	6.81e-05	0.000394	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—breast cancer	6.8e-05	0.000394	CcSEcCtD
Hydroxocobalamin—Headache—Mitoxantrone—breast cancer	6.77e-05	0.000392	CcSEcCtD
Hydroxocobalamin—Headache—Irinotecan—breast cancer	6.77e-05	0.000392	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Docetaxel—breast cancer	6.66e-05	0.000386	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—breast cancer	6.64e-05	0.000384	CcSEcCtD
Hydroxocobalamin—Rash—Gemcitabine—breast cancer	6.64e-05	0.000384	CcSEcCtD
Hydroxocobalamin—Dermatitis—Gemcitabine—breast cancer	6.63e-05	0.000384	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—breast cancer	6.63e-05	0.000384	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—breast cancer	6.6e-05	0.000382	CcSEcCtD
Hydroxocobalamin—Headache—Gemcitabine—breast cancer	6.6e-05	0.000382	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—breast cancer	6.58e-05	0.000381	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Docetaxel—breast cancer	6.58e-05	0.000381	CcSEcCtD
Hydroxocobalamin—Rash—Fluorouracil—breast cancer	6.53e-05	0.000378	CcSEcCtD
Hydroxocobalamin—Dermatitis—Fluorouracil—breast cancer	6.52e-05	0.000377	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Paclitaxel—breast cancer	6.5e-05	0.000376	CcSEcCtD
Hydroxocobalamin—Headache—Fluorouracil—breast cancer	6.49e-05	0.000375	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—breast cancer	6.48e-05	0.000375	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—breast cancer	6.47e-05	0.000374	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Docetaxel—breast cancer	6.45e-05	0.000373	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Capecitabine—breast cancer	6.45e-05	0.000373	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—breast cancer	6.44e-05	0.000372	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—breast cancer	6.43e-05	0.000372	CcSEcCtD
Hydroxocobalamin—Nausea—Irinotecan—breast cancer	6.42e-05	0.000372	CcSEcCtD
Hydroxocobalamin—Nausea—Mitoxantrone—breast cancer	6.42e-05	0.000372	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—breast cancer	6.41e-05	0.000371	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—breast cancer	6.39e-05	0.00037	CcSEcCtD
Hydroxocobalamin—Pain—Docetaxel—breast cancer	6.39e-05	0.00037	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Capecitabine—breast cancer	6.37e-05	0.000369	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—breast cancer	6.37e-05	0.000368	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—breast cancer	6.34e-05	0.000367	CcSEcCtD
Hydroxocobalamin—Nausea—Gemcitabine—breast cancer	6.25e-05	0.000362	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Capecitabine—breast cancer	6.25e-05	0.000361	CcSEcCtD
Hydroxocobalamin—Pruritus—Paclitaxel—breast cancer	6.24e-05	0.000361	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—breast cancer	6.22e-05	0.00036	CcSEcCtD
Hydroxocobalamin—Pain—Capecitabine—breast cancer	6.19e-05	0.000358	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—breast cancer	6.18e-05	0.000357	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Docetaxel—breast cancer	6.16e-05	0.000356	CcSEcCtD
Hydroxocobalamin—Nausea—Fluorouracil—breast cancer	6.15e-05	0.000356	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—breast cancer	6.13e-05	0.000355	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—breast cancer	6.12e-05	0.000354	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—breast cancer	6.09e-05	0.000353	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Paclitaxel—breast cancer	6.03e-05	0.000349	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Capecitabine—breast cancer	5.96e-05	0.000345	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—breast cancer	5.96e-05	0.000345	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—breast cancer	5.95e-05	0.000344	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—breast cancer	5.93e-05	0.000343	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—breast cancer	5.92e-05	0.000342	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Docetaxel—breast cancer	5.91e-05	0.000342	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—breast cancer	5.89e-05	0.000341	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—breast cancer	5.86e-05	0.000339	CcSEcCtD
Hydroxocobalamin—Dizziness—Paclitaxel—breast cancer	5.83e-05	0.000337	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—breast cancer	5.75e-05	0.000333	CcSEcCtD
Hydroxocobalamin—Urticaria—Capecitabine—breast cancer	5.75e-05	0.000333	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—breast cancer	5.73e-05	0.000332	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Capecitabine—breast cancer	5.72e-05	0.000331	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—breast cancer	5.71e-05	0.000331	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—breast cancer	5.68e-05	0.000328	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—breast cancer	5.62e-05	0.000325	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.58e-05	0.000323	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—breast cancer	5.57e-05	0.000322	CcSEcCtD
Hydroxocobalamin—Rash—Paclitaxel—breast cancer	5.56e-05	0.000322	CcSEcCtD
Hydroxocobalamin—Dermatitis—Paclitaxel—breast cancer	5.55e-05	0.000321	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—breast cancer	5.55e-05	0.000321	CcSEcCtD
Hydroxocobalamin—Headache—Paclitaxel—breast cancer	5.52e-05	0.00032	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Docetaxel—breast cancer	5.51e-05	0.000319	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—breast cancer	5.39e-05	0.000312	CcSEcCtD
Hydroxocobalamin—Infection—Methotrexate—breast cancer	5.35e-05	0.00031	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Capecitabine—breast cancer	5.33e-05	0.000308	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—breast cancer	5.3e-05	0.000307	CcSEcCtD
Hydroxocobalamin—Pruritus—Docetaxel—breast cancer	5.29e-05	0.000306	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—breast cancer	5.28e-05	0.000306	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—breast cancer	5.26e-05	0.000304	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—breast cancer	5.25e-05	0.000304	CcSEcCtD
Hydroxocobalamin—Nausea—Paclitaxel—breast cancer	5.24e-05	0.000303	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—breast cancer	5.23e-05	0.000303	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.22e-05	0.000302	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—breast cancer	5.19e-05	0.000301	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—breast cancer	5.15e-05	0.000298	CcSEcCtD
Hydroxocobalamin—Pruritus—Capecitabine—breast cancer	5.12e-05	0.000296	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Docetaxel—breast cancer	5.11e-05	0.000296	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—breast cancer	5.04e-05	0.000292	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—breast cancer	5.04e-05	0.000292	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—breast cancer	5.01e-05	0.00029	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Capecitabine—breast cancer	4.95e-05	0.000286	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—breast cancer	4.94e-05	0.000286	CcSEcCtD
Hydroxocobalamin—Dizziness—Docetaxel—breast cancer	4.94e-05	0.000286	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—breast cancer	4.92e-05	0.000285	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—breast cancer	4.9e-05	0.000283	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—breast cancer	4.86e-05	0.000282	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.83e-05	0.00028	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—breast cancer	4.81e-05	0.000278	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Methotrexate—breast cancer	4.8e-05	0.000278	CcSEcCtD
Hydroxocobalamin—Dizziness—Capecitabine—breast cancer	4.78e-05	0.000277	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Methotrexate—breast cancer	4.74e-05	0.000274	CcSEcCtD
Hydroxocobalamin—Rash—Docetaxel—breast cancer	4.71e-05	0.000273	CcSEcCtD
Hydroxocobalamin—Dermatitis—Docetaxel—breast cancer	4.71e-05	0.000272	CcSEcCtD
Hydroxocobalamin—Headache—Docetaxel—breast cancer	4.68e-05	0.000271	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—breast cancer	4.66e-05	0.00027	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—breast cancer	4.66e-05	0.00027	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—breast cancer	4.65e-05	0.000269	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—breast cancer	4.63e-05	0.000268	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—breast cancer	4.61e-05	0.000267	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—breast cancer	4.57e-05	0.000265	CcSEcCtD
Hydroxocobalamin—Rash—Capecitabine—breast cancer	4.56e-05	0.000264	CcSEcCtD
Hydroxocobalamin—Dermatitis—Capecitabine—breast cancer	4.56e-05	0.000264	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—breast cancer	4.55e-05	0.000263	CcSEcCtD
Hydroxocobalamin—Headache—Capecitabine—breast cancer	4.53e-05	0.000262	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—breast cancer	4.53e-05	0.000262	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—breast cancer	4.49e-05	0.00026	CcSEcCtD
Hydroxocobalamin—Nausea—Docetaxel—breast cancer	4.44e-05	0.000257	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methotrexate—breast cancer	4.44e-05	0.000257	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—breast cancer	4.44e-05	0.000257	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—breast cancer	4.35e-05	0.000252	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—breast cancer	4.31e-05	0.000249	CcSEcCtD
Hydroxocobalamin—Nausea—Capecitabine—breast cancer	4.3e-05	0.000249	CcSEcCtD
Hydroxocobalamin—Urticaria—Methotrexate—breast cancer	4.28e-05	0.000248	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—breast cancer	4.26e-05	0.000246	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—breast cancer	4.16e-05	0.000241	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—breast cancer	4.15e-05	0.00024	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—breast cancer	4.11e-05	0.000238	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—breast cancer	4.03e-05	0.000233	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—breast cancer	4e-05	0.000232	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—breast cancer	3.99e-05	0.000231	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—breast cancer	3.98e-05	0.000231	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methotrexate—breast cancer	3.97e-05	0.00023	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—breast cancer	3.84e-05	0.000222	CcSEcCtD
Hydroxocobalamin—Pruritus—Methotrexate—breast cancer	3.81e-05	0.000221	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—breast cancer	3.71e-05	0.000215	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—breast cancer	3.7e-05	0.000214	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—breast cancer	3.69e-05	0.000213	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—breast cancer	3.69e-05	0.000213	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—breast cancer	3.57e-05	0.000206	CcSEcCtD
Hydroxocobalamin—Dizziness—Methotrexate—breast cancer	3.56e-05	0.000206	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—breast cancer	3.45e-05	0.0002	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—breast cancer	3.44e-05	0.000199	CcSEcCtD
Hydroxocobalamin—Rash—Methotrexate—breast cancer	3.4e-05	0.000197	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—breast cancer	3.39e-05	0.000196	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—breast cancer	3.37e-05	0.000195	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—breast cancer	3.33e-05	0.000193	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—breast cancer	3.3e-05	0.000191	CcSEcCtD
Hydroxocobalamin—Nausea—Methotrexate—breast cancer	3.2e-05	0.000185	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—breast cancer	3.19e-05	0.000185	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—breast cancer	3.18e-05	0.000184	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—breast cancer	3.18e-05	0.000184	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—breast cancer	3.16e-05	0.000183	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—breast cancer	3.08e-05	0.000178	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—breast cancer	2.99e-05	0.000173	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—breast cancer	2.94e-05	0.00017	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—breast cancer	2.94e-05	0.00017	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—breast cancer	2.92e-05	0.000169	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—breast cancer	2.77e-05	0.00016	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling Pathways—AGTR1—breast cancer	6.04e-06	3e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—breast cancer	6.04e-06	3e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—breast cancer	6.04e-06	3e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK3—breast cancer	6.02e-06	2.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NFKBIA—breast cancer	6e-06	2.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—breast cancer	5.97e-06	2.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADAM10—breast cancer	5.95e-06	2.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STK11—breast cancer	5.95e-06	2.96e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—breast cancer	5.94e-06	2.95e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS3—breast cancer	5.92e-06	2.94e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—breast cancer	5.9e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CAV1—breast cancer	5.89e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLG—breast cancer	5.89e-06	2.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SRC—breast cancer	5.88e-06	2.92e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—breast cancer	5.87e-06	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—breast cancer	5.86e-06	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—breast cancer	5.86e-06	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—breast cancer	5.84e-06	2.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—breast cancer	5.81e-06	2.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1A—breast cancer	5.8e-06	2.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF10—breast cancer	5.79e-06	2.88e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—breast cancer	5.79e-06	2.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGF—breast cancer	5.75e-06	2.85e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—breast cancer	5.73e-06	2.85e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—breast cancer	5.71e-06	2.84e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—breast cancer	5.71e-06	2.84e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—breast cancer	5.65e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—breast cancer	5.65e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK3—breast cancer	5.65e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MDM2—breast cancer	5.61e-06	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—breast cancer	5.61e-06	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CB—breast cancer	5.61e-06	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—RAF1—breast cancer	5.59e-06	2.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFA—breast cancer	5.59e-06	2.78e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—breast cancer	5.57e-06	2.77e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—breast cancer	5.57e-06	2.77e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—breast cancer	5.56e-06	2.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FOS—breast cancer	5.54e-06	2.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS2—breast cancer	5.54e-06	2.75e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—breast cancer	5.53e-06	2.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFBR2—breast cancer	5.51e-06	2.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOTCH1—breast cancer	5.49e-06	2.73e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CB—breast cancer	5.46e-06	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTOR—breast cancer	5.46e-06	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD4—breast cancer	5.45e-06	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ITPR1—breast cancer	5.42e-06	2.69e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—breast cancer	5.41e-06	2.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CASP8—breast cancer	5.41e-06	2.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—breast cancer	5.41e-06	2.69e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—breast cancer	5.39e-06	2.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB4—breast cancer	5.38e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT5A—breast cancer	5.38e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP3—breast cancer	5.38e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—breast cancer	5.37e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SRC—breast cancer	5.37e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—breast cancer	5.37e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APC—breast cancer	5.37e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—breast cancer	5.35e-06	2.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT2—breast cancer	5.32e-06	2.64e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—breast cancer	5.31e-06	2.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGF—breast cancer	5.3e-06	2.64e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CD—breast cancer	5.25e-06	2.61e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—breast cancer	5.23e-06	2.6e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—breast cancer	5.23e-06	2.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SMAD4—breast cancer	5.21e-06	2.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1R—breast cancer	5.18e-06	2.57e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ALB—breast cancer	5.18e-06	2.57e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—breast cancer	5.18e-06	2.57e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—breast cancer	5.18e-06	2.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—breast cancer	5.16e-06	2.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1B—breast cancer	5.13e-06	2.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CD—breast cancer	5.11e-06	2.54e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—breast cancer	5.1e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HES1—breast cancer	5.09e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—breast cancer	5.07e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLA2G4A—breast cancer	5.06e-06	2.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NCOR1—breast cancer	5.06e-06	2.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—breast cancer	5.04e-06	2.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF1—breast cancer	5e-06	2.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CSF2—breast cancer	5e-06	2.49e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—breast cancer	5e-06	2.49e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—breast cancer	5e-06	2.49e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—breast cancer	4.99e-06	2.48e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—breast cancer	4.97e-06	2.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRG1—breast cancer	4.97e-06	2.47e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NOS3—breast cancer	4.96e-06	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK3—breast cancer	4.95e-06	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—H2AFX—breast cancer	4.93e-06	2.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT2—breast cancer	4.91e-06	2.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—E2F1—breast cancer	4.9e-06	2.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—breast cancer	4.87e-06	2.42e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—breast cancer	4.85e-06	2.41e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—breast cancer	4.84e-06	2.41e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—breast cancer	4.81e-06	2.39e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—breast cancer	4.8e-06	2.38e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—breast cancer	4.77e-06	2.37e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—breast cancer	4.73e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—breast cancer	4.73e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1A—breast cancer	4.73e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—breast cancer	4.72e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CD—breast cancer	4.72e-06	2.34e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—breast cancer	4.71e-06	2.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SPP1—breast cancer	4.71e-06	2.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SERPINE1—breast cancer	4.67e-06	2.32e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—breast cancer	4.66e-06	2.32e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—breast cancer	4.66e-06	2.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—breast cancer	4.66e-06	2.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB3—breast cancer	4.65e-06	2.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR2—breast cancer	4.65e-06	2.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—breast cancer	4.65e-06	2.31e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—breast cancer	4.62e-06	2.29e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—breast cancer	4.62e-06	2.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNG—breast cancer	4.6e-06	2.29e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—breast cancer	4.6e-06	2.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MDM2—breast cancer	4.58e-06	2.27e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CB—breast cancer	4.57e-06	2.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RAF1—breast cancer	4.56e-06	2.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RELA—breast cancer	4.54e-06	2.26e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—breast cancer	4.53e-06	2.25e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—breast cancer	4.51e-06	2.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—breast cancer	4.51e-06	2.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—breast cancer	4.48e-06	2.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—breast cancer	4.46e-06	2.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS3—breast cancer	4.45e-06	2.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MTOR—breast cancer	4.45e-06	2.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CB—breast cancer	4.45e-06	2.21e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—breast cancer	4.45e-06	2.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD4—breast cancer	4.45e-06	2.21e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—breast cancer	4.4e-06	2.19e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—breast cancer	4.4e-06	2.19e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SRC—breast cancer	4.38e-06	2.17e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—breast cancer	4.34e-06	2.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR1—breast cancer	4.33e-06	2.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—breast cancer	4.31e-06	2.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—breast cancer	4.27e-06	2.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MDM2—breast cancer	4.23e-06	2.1e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—breast cancer	4.22e-06	2.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—RAF1—breast cancer	4.21e-06	2.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1B—breast cancer	4.18e-06	2.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—breast cancer	4.17e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—breast cancer	4.17e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LEP—breast cancer	4.16e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—breast cancer	4.14e-06	2.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—breast cancer	4.13e-06	2.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CAV1—breast cancer	4.13e-06	2.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CB—breast cancer	4.11e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTOR—breast cancer	4.11e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL1B—breast cancer	4.11e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD4—breast cancer	4.1e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—breast cancer	4.09e-06	2.03e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—breast cancer	4.08e-06	2.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—breast cancer	4.08e-06	2.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—breast cancer	4.07e-06	2.02e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—breast cancer	4.06e-06	2.02e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK3—breast cancer	4.03e-06	2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JUN—breast cancer	3.98e-06	1.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ESR1—breast cancer	3.98e-06	1.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—breast cancer	3.95e-06	1.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—breast cancer	3.95e-06	1.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FN1—breast cancer	3.93e-06	1.95e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—breast cancer	3.92e-06	1.95e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—breast cancer	3.91e-06	1.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NFKBIA—breast cancer	3.88e-06	1.93e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—breast cancer	3.86e-06	1.92e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—breast cancer	3.86e-06	1.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1B—breast cancer	3.86e-06	1.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1A—breast cancer	3.86e-06	1.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—breast cancer	3.85e-06	1.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH1—breast cancer	3.84e-06	1.91e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—breast cancer	3.84e-06	1.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—breast cancer	3.81e-06	1.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—breast cancer	3.78e-06	1.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK8—breast cancer	3.76e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—breast cancer	3.76e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—breast cancer	3.76e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APC—breast cancer	3.76e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGF—breast cancer	3.71e-06	1.85e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—breast cancer	3.69e-06	1.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—breast cancer	3.66e-06	1.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—breast cancer	3.65e-06	1.81e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—breast cancer	3.62e-06	1.8e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—breast cancer	3.62e-06	1.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SRC—breast cancer	3.57e-06	1.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1A—breast cancer	3.56e-06	1.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—breast cancer	3.55e-06	1.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—breast cancer	3.53e-06	1.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—breast cancer	3.44e-06	1.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1—breast cancer	3.44e-06	1.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT2—breast cancer	3.44e-06	1.71e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—breast cancer	3.42e-06	1.7e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—breast cancer	3.4e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—breast cancer	3.34e-06	1.66e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—breast cancer	3.33e-06	1.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CD—breast cancer	3.3e-06	1.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SRC—breast cancer	3.3e-06	1.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK3—breast cancer	3.29e-06	1.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SERPINE1—breast cancer	3.27e-06	1.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—breast cancer	3.18e-06	1.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—breast cancer	3.13e-06	1.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOS3—breast cancer	3.12e-06	1.55e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—breast cancer	3.08e-06	1.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK3—breast cancer	3.04e-06	1.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MDM2—breast cancer	2.96e-06	1.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—breast cancer	2.96e-06	1.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—breast cancer	2.95e-06	1.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RAF1—breast cancer	2.95e-06	1.47e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—breast cancer	2.95e-06	1.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—breast cancer	2.95e-06	1.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RELA—breast cancer	2.94e-06	1.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—breast cancer	2.92e-06	1.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—breast cancer	2.89e-06	1.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CB—breast cancer	2.88e-06	1.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MTOR—breast cancer	2.88e-06	1.43e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—breast cancer	2.79e-06	1.39e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—breast cancer	2.79e-06	1.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—breast cancer	2.77e-06	1.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—breast cancer	2.73e-06	1.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—breast cancer	2.72e-06	1.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—breast cancer	2.72e-06	1.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1B—breast cancer	2.7e-06	1.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—breast cancer	2.65e-06	1.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—breast cancer	2.64e-06	1.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—breast cancer	2.58e-06	1.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUN—breast cancer	2.57e-06	1.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—breast cancer	2.55e-06	1.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—breast cancer	2.51e-06	1.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—breast cancer	2.51e-06	1.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—breast cancer	2.5e-06	1.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1A—breast cancer	2.49e-06	1.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—breast cancer	2.49e-06	1.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK8—breast cancer	2.43e-06	1.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—breast cancer	2.4e-06	1.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—breast cancer	2.32e-06	1.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SRC—breast cancer	2.31e-06	1.15e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—breast cancer	2.28e-06	1.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—breast cancer	2.25e-06	1.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—breast cancer	2.23e-06	1.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—breast cancer	2.22e-06	1.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—breast cancer	2.22e-06	1.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK3—breast cancer	2.13e-06	1.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—breast cancer	2.07e-06	1.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—breast cancer	2.06e-06	1.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—breast cancer	2.05e-06	1.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—breast cancer	2.02e-06	1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—breast cancer	1.91e-06	9.49e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—breast cancer	1.76e-06	8.72e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—breast cancer	1.7e-06	8.44e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—breast cancer	1.62e-06	8.07e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—breast cancer	1.55e-06	7.72e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—breast cancer	1.43e-06	7.13e-06	CbGpPWpGaD
